期刊文献+

P27在乳腺癌中的表达及其临床意义 被引量:1

Expression and clinical significance of P27 in breast carcinoma
下载PDF
导出
摘要 目的 研究 P2 7在乳腺癌中的表达及临床意义。方法 应用免疫组化 S- P法对 5 0例乳腺癌组织、4 5例癌旁正常乳腺组织、5 0例良性乳腺组织 P2 7的表达进行检测。结果  P2 7蛋白在乳腺癌组织、癌旁正常乳腺组织、良性乳腺组织阳性表达率分析为 5 4 %、6 0 %和 76 % ,P2 7蛋白在乳腺癌组织中表达与其在良性乳腺组织中表达相比有显著性差异 (P <0 .0 5 ) ,与其乳腺癌癌旁组织相比无统计学差异 ;P2 7蛋白在乳腺癌组织中表达与腋淋巴结状态及临床分期相关 ,而与年龄、肿瘤大小、ER和PR的表达无关。结论  P2 7可能与乳腺癌发生、发展及腋淋巴结转移有关 ,P2 7蛋白的表达对判断乳腺癌临床进展有一定的参考价值。 Objective To investigate the expression and clinical significance of P27 in breast carcinoma.Methods The expression of P27 was determined by S-P immunohistochemical technique method in 50 cases of breast carcinoma,45 cases of normal tissue around breast carcinoma,50 cases of benign breast tissue.Results Positive expression rates of P27 protein is 54% in breast carcinoma,60% in normal tissue around breast carcinoma,and 76% in benign breast tissue.The difference between benign breast tissue and breast carcinoma was prominent(P<0.05),but not between breast carcinoma and normal tissue around breast carcinoma.Statistical correlation existed between P27 protein and the lymph node metastasis,clinical stages,but not between P27 protein and age,sizes of tumor,expression of ER and PR.Conclusion The expression of P27 probably is associated with the development of breast carcinoma and lymph node metastasis;The expression of P27 can be used in prediction of the clinical progression of breast carcinoma.
出处 《广西医学》 CAS 2004年第2期176-178,共3页 Guangxi Medical Journal
关键词 P27 乳腺癌 表达 免疫组化 P27 Breast carcinoma Immunohistochemistry
  • 相关文献

参考文献7

  • 1Sherr CJ. Cancer cell cycle[J]. Science, 1996,274(5 293):1672-- 1677.
  • 2Catzovelos C,Bhattabharya N,Ung YC.et al. Decreased levels of the cell cycle inhibitor P27kipl protein:prognostic implications in primary breast cancer [J]. Nat Med,1997,3(2) :227--230.
  • 3Porter PL,Malone KE,Heagerty PJ,et al. Expression of cell-cycle regulators P27kipl and cyclinE, alone and in combination, correlate with survival in young breast cancer patients[J]. Nat Med, 1997,3(2):222--225.
  • 4Barbareschi M .Tinteren H V,Mauri F A.et al. P27kipl expression in breast carcinomas: an immunohistochemical study on 512 patients with long term follow up[J]. Int J Cancer,2000,89(3):236-241.
  • 5Singh SP, Lipman J, Goldman H, et al. Loss or altered subcellular localization of P27 in Barrett's associated adenocarcinoma [J]. Cancer Res,1998,58:1730-1735.
  • 6曹红亮,张广德,夏文华,肖继平,陈爱军.p27蛋白在乳腺癌中的表达与预后的关系[J].癌症,2000,19(3):239-241. 被引量:6
  • 7Tan P,Cady B,Wanner M,et al. The cell cycle inhibitor P27 is an independent prognostic marker in small (Tla. b ) invaslve breast carcinomas[J]. Cancer Res,1997,57(7) :1 259-1 263.

二级参考文献2

  • 1Yang R M,J Urol,1998年,159期,941页
  • 2Tan P,Cancer Res,1997年,57期,1259页

共引文献5

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部